European Heart Journal最新文献

筛选
英文 中文
Mediterranean diet, neutrophil count, and atherosclerosis. 地中海饮食,中性粒细胞计数和动脉粥样硬化。
IF 37.6 1区 医学
European Heart Journal Pub Date : 2025-07-14 DOI: 10.1093/eurheartj/ehaf169
Christian Saleh, Knarik Hovhannisyan, Hrvoje Budincevic
{"title":"Mediterranean diet, neutrophil count, and atherosclerosis.","authors":"Christian Saleh, Knarik Hovhannisyan, Hrvoje Budincevic","doi":"10.1093/eurheartj/ehaf169","DOIUrl":"10.1093/eurheartj/ehaf169","url":null,"abstract":"","PeriodicalId":11976,"journal":{"name":"European Heart Journal","volume":" ","pages":"2709"},"PeriodicalIF":37.6,"publicationDate":"2025-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143810827","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The double-edged sword of heart rate lowering in cardiovascular disease. 心血管疾病降低心率的双刃剑。
IF 37.6 1区 医学
European Heart Journal Pub Date : 2025-07-14 DOI: 10.1093/eurheartj/ehaf310
Franz H Messerli, Louis Hofstetter, Sripal Bangalore
{"title":"The double-edged sword of heart rate lowering in cardiovascular disease.","authors":"Franz H Messerli, Louis Hofstetter, Sripal Bangalore","doi":"10.1093/eurheartj/ehaf310","DOIUrl":"10.1093/eurheartj/ehaf310","url":null,"abstract":"","PeriodicalId":11976,"journal":{"name":"European Heart Journal","volume":" ","pages":"2670-2672"},"PeriodicalIF":37.6,"publicationDate":"2025-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144224803","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Xylitol and cardiovascular risks. 木糖醇和心血管风险。
IF 37.6 1区 医学
European Heart Journal Pub Date : 2025-07-14 DOI: 10.1093/eurheartj/ehaf059
Marco Witkowski, Stanley L Hazen
{"title":"Xylitol and cardiovascular risks.","authors":"Marco Witkowski, Stanley L Hazen","doi":"10.1093/eurheartj/ehaf059","DOIUrl":"10.1093/eurheartj/ehaf059","url":null,"abstract":"","PeriodicalId":11976,"journal":{"name":"European Heart Journal","volume":" ","pages":"2707-2708"},"PeriodicalIF":37.6,"publicationDate":"2025-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143603751","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Discussion on Mediterranean diet, neutrophil count, and atherosclerosis. 讨论地中海饮食、中性粒细胞计数和动脉粥样硬化。
IF 37.6 1区 医学
European Heart Journal Pub Date : 2025-07-14 DOI: 10.1093/eurheartj/ehaf171
Jose Lopez-Miranda
{"title":"Discussion on Mediterranean diet, neutrophil count, and atherosclerosis.","authors":"Jose Lopez-Miranda","doi":"10.1093/eurheartj/ehaf171","DOIUrl":"10.1093/eurheartj/ehaf171","url":null,"abstract":"","PeriodicalId":11976,"journal":{"name":"European Heart Journal","volume":" ","pages":"2710-2711"},"PeriodicalIF":37.6,"publicationDate":"2025-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143810823","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction to: Hospitalization for cardiovascular disease in the year after delivery of twin pregnancies. 更正:双胎妊娠分娩后一年内因心血管疾病住院。
IF 39.3 1区 医学
European Heart Journal Pub Date : 2025-07-11 DOI: 10.1093/eurheartj/ehaf263
{"title":"Correction to: Hospitalization for cardiovascular disease in the year after delivery of twin pregnancies.","authors":"","doi":"10.1093/eurheartj/ehaf263","DOIUrl":"https://doi.org/10.1093/eurheartj/ehaf263","url":null,"abstract":"","PeriodicalId":11976,"journal":{"name":"European Heart Journal","volume":"11 1","pages":""},"PeriodicalIF":39.3,"publicationDate":"2025-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144603894","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Infected native aortic aneurysms: epidemiology, management, and outcomes based on a nationwide population-based study 受感染的原生主动脉瘤:流行病学、管理和基于全国人口研究的结果
IF 39.3 1区 医学
European Heart Journal Pub Date : 2025-07-11 DOI: 10.1093/eurheartj/ehaf449
Chih-Chun Lee, Feng-Cheng Chang, Ming-Jer Hsieh, Chun-Yu Chen, Jih-Kai Yeh, Victor Chien-Chia Wu, Yi-Hsin Chan, Yu-Ting Cheng, Pao-Hsien Chu, Shao-Wei Chen
{"title":"Infected native aortic aneurysms: epidemiology, management, and outcomes based on a nationwide population-based study","authors":"Chih-Chun Lee, Feng-Cheng Chang, Ming-Jer Hsieh, Chun-Yu Chen, Jih-Kai Yeh, Victor Chien-Chia Wu, Yi-Hsin Chan, Yu-Ting Cheng, Pao-Hsien Chu, Shao-Wei Chen","doi":"10.1093/eurheartj/ehaf449","DOIUrl":"https://doi.org/10.1093/eurheartj/ehaf449","url":null,"abstract":"Background and Aims Large-scale investigations with longitudinal data on infected native aortic aneurysms (INAAs), a rare but life-threatening emergency, are lacking. The epidemiology, treatment trends, and outcomes of INAAs were investigated in a nationwide population-based cohort. Methods A total of 2387 hospitalisations for INAAs were identified between 2001 and 2021 in the Taiwanese National Health Insurance Research Database. A retrospective cohort was analysed using data spanning a 21-year study period. In-hospital and post-discharge adverse events, including 1-, 3-, 5- and 10-year mortality, were assessed. Results The cohort had a mean age of 73.8 ± 11.8 years, with 77.6% being men. There was an increasing trend in INAAs over time, with a high prevalence of comorbid renal insufficiency (53%). Most patients were treated with third-generation cephalosporins and anti-methicillin-resistant Staphylococcus aureus agents. Conservative treatment was associated with the highest mortality rates, including in-hospital death and post-discharge death. The risk of in-hospital mortality was significantly lower in the endovascular aortic repair (EVAR) group compared with the open repair group [odds ratio 0.76, 95% confidence interval (CI): 0.63–0.91]. At the end of follow-up, patients who underwent EVAR demonstrated high mortality risks (hazard ratio 1.13, 95% CI: 1.04–1.23 at the end of follow-up) than open repair. Conclusions Surgical repair is associated with significantly more favourable post-discharge survival compared with EVAR, underscoring the importance of open repair for optimal management of INAAs. In selected high-risk patients, EVAR may serve as a temporising or palliative option, particularly when definitive open repair is not immediately feasible.","PeriodicalId":11976,"journal":{"name":"European Heart Journal","volume":"4 1","pages":""},"PeriodicalIF":39.3,"publicationDate":"2025-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144602883","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mitral valve replacement or repair and long-term risk of infective endocarditis: a Danish nationwide study. 二尖瓣置换术或修复术与感染性心内膜炎的长期风险:一项丹麦全国性研究。
IF 39.3 1区 医学
European Heart Journal Pub Date : 2025-07-11 DOI: 10.1093/eurheartj/ehaf342
Amna Alhakak,Jawad Haider Butt,Eva Havers-Borgersen,Lauge Østergaard,Peter Laursen Graversen,Jarl Emanuel Strange,Katia Al-Chaer,Morten Holdgaard Smerup,Henning Bundgaard,Lars Køber,Emil Loldrup Fosbøl
{"title":"Mitral valve replacement or repair and long-term risk of infective endocarditis: a Danish nationwide study.","authors":"Amna Alhakak,Jawad Haider Butt,Eva Havers-Borgersen,Lauge Østergaard,Peter Laursen Graversen,Jarl Emanuel Strange,Katia Al-Chaer,Morten Holdgaard Smerup,Henning Bundgaard,Lars Køber,Emil Loldrup Fosbøl","doi":"10.1093/eurheartj/ehaf342","DOIUrl":"https://doi.org/10.1093/eurheartj/ehaf342","url":null,"abstract":"BACKGROUND AND AIMSInfective endocarditis (IE) after mitral valve (MV) interventions is a serious complication. However, information on the long-term risk of first-time IE after MV replacement or repair is lacking. The 10-year incidence of first-time IE was examined in patients undergoing MV replacement or repair, compared with those at moderate risk of IE.METHODSUsing Danish nationwide registries (2000-2020), the study population included patients undergoing isolated MV replacement or repair and patients at moderate risk of IE. The moderate-risk group included cardiac implantable electronic devices, congenital heart valve anomalies, hypertrophic cardiomyopathy, rheumatic heart diseases, and non-rheumatic degenerative valve diseases. The Aalen-Johansen estimator and cause-specific Cox regression models were used to determine the 10-year comparative incidences of IE.RESULTSThe study population included 1220 patients undergoing MV replacement, 3239 undergoing MV repair, and 209 517 at moderate risk of IE. The 10-year cumulative incidences of IE were 6.1% [95% confidence interval (CI) 4.8%-7.7%] for MV replacement, 1.6% (95% CI 1.1%-2.1%) for MV repair, and 1.7% (95% CI 1.6%-1.7%) for the moderate-risk group. Compared with the moderate-risk group, after multivariable adjustment, MV replacement was associated with a higher 10-year IE rate (hazard ratio 3.52, 95% CI 2.73-4.52), whereas MV repair was not associated with IE (hazard ratio 0.76, 95% CI 0.56-1.04).CONCLUSIONSIn this nationwide study, MV replacement was associated with a 3.5-fold increased 10-year IE rate, whereas MV repair was not significantly associated with IE, compared with patients at moderate risk of IE. These findings highlight the need for further investigation into preventive measures, including targeted antibiotic prophylaxis.","PeriodicalId":11976,"journal":{"name":"European Heart Journal","volume":"4 1","pages":""},"PeriodicalIF":39.3,"publicationDate":"2025-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144603968","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Profound iodine enhancement of the myocardium on a native CT scan one hour after invasive coronary angiography and revascularization. 有创冠状动脉造影术和血运重建术后1小时的原生CT扫描显示心肌深度碘增强。
IF 39.3 1区 医学
European Heart Journal Pub Date : 2025-07-11 DOI: 10.1093/eurheartj/ehaf490
Stefan Gherca,Jasper Boeddinghaus,Philip Haaf
{"title":"Profound iodine enhancement of the myocardium on a native CT scan one hour after invasive coronary angiography and revascularization.","authors":"Stefan Gherca,Jasper Boeddinghaus,Philip Haaf","doi":"10.1093/eurheartj/ehaf490","DOIUrl":"https://doi.org/10.1093/eurheartj/ehaf490","url":null,"abstract":"","PeriodicalId":11976,"journal":{"name":"European Heart Journal","volume":"114 1","pages":""},"PeriodicalIF":39.3,"publicationDate":"2025-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144603966","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unveiling the risk of infective endocarditis after mitral valve replacement and mitral valve repair. 揭示二尖瓣置换术和二尖瓣修复术后感染性心内膜炎的风险。
IF 39.3 1区 医学
European Heart Journal Pub Date : 2025-07-11 DOI: 10.1093/eurheartj/ehaf099
Daniele Giacoppo
{"title":"Unveiling the risk of infective endocarditis after mitral valve replacement and mitral valve repair.","authors":"Daniele Giacoppo","doi":"10.1093/eurheartj/ehaf099","DOIUrl":"https://doi.org/10.1093/eurheartj/ehaf099","url":null,"abstract":"","PeriodicalId":11976,"journal":{"name":"European Heart Journal","volume":"107 1","pages":""},"PeriodicalIF":39.3,"publicationDate":"2025-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144603969","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sex differences in dual antiplatelet therapy de-escalation strategies after percutaneous coronary intervention: a network meta-analysis 经皮冠状动脉介入治疗后双重抗血小板治疗降压策略的性别差异:网络荟萃分析
IF 39.3 1区 医学
European Heart Journal Pub Date : 2025-07-11 DOI: 10.1093/eurheartj/ehaf473
Giovanni Occhipinti, Claudio Laudani, Mattia Galli, Luis Ortega-Paz, Vijay Kunadian, Guiomar Mendieta, Riccardo Rinaldi, Felicita Andreotti, Roxana Mehran, Teresa López-Sobrino, Davide Capodanno, Dominick J Angiolillo, Manel Sabaté Tenas, Salvatore Brugaletta
{"title":"Sex differences in dual antiplatelet therapy de-escalation strategies after percutaneous coronary intervention: a network meta-analysis","authors":"Giovanni Occhipinti, Claudio Laudani, Mattia Galli, Luis Ortega-Paz, Vijay Kunadian, Guiomar Mendieta, Riccardo Rinaldi, Felicita Andreotti, Roxana Mehran, Teresa López-Sobrino, Davide Capodanno, Dominick J Angiolillo, Manel Sabaté Tenas, Salvatore Brugaletta","doi":"10.1093/eurheartj/ehaf473","DOIUrl":"https://doi.org/10.1093/eurheartj/ehaf473","url":null,"abstract":"Background and Aims Dual antiplatelet therapy (DAPT) de-escalation strategies improve outcomes after percutaneous coronary intervention (PCI) compared to standard DAPT. However, the potential impact of sex on the safety and efficacy of these strategies is yet to be fully investigated. Methods Randomized controlled trials comparing de-escalated vs standard DAPT regimens in patients without baseline indication for oral anticoagulation reporting outcomes stratified by sex were included. The co-primary endpoints were trial-defined major adverse cardiovascular events (MACE) and major bleeding. Hazard ratios (HR) with 95% confidence intervals (CI) were computed to account for different follow-up durations. A network meta-analysis including ranking of treatments was performed to explore the comparative effects of different DAPT de-escalation strategies among females and males. Results Overall, 71 272 patients from 20 trials were included, and 23.3% were female. De-escalation strategies were grouped into (1) DAPT discontinuation, by aspirin or the P2Y12 inhibitor; or (2) P2Y12 inhibitor switch or dose reduction. With DAPT discontinuation vs standard DAPT, a significant interaction between treatment effect and sex was found for both MACE (Pint = .028) and major bleeding (Pint = .015). Indeed, DAPT discontinuation reduced MACE in females (HR, 0.86; 95% CI, 0.75–0.98) but not in males (HR, 1.04; 95% CI 0.93–1.16), while reducing major bleeding in males (HR, 0.60; 95% CI, 0.44–0.82) but not in females (HR, 1.04; 95% CI, 0.76–1.43), compared to standard DAPT. Conversely, no interactions by sex were found with P2Y12 inhibitor switch or dose reduction vs standard DAPT for both MACE (Pint = .668) and major bleeding (Pint = .858). At treatment ranking, aspirin discontinuation ranked best for most outcomes in females, while P2Y12 inhibitor switch to clopidogrel showed the best outcomes in males. Conclusions Sex may influence the safety and efficacy of antiplatelet de-escalation strategies after PCI, particularly those involving the shortening of DAPT. Aspirin discontinuation may represent the optimal strategy for females, while P2Y12 inhibitor switch to clopidogrel may be most effective for males.","PeriodicalId":11976,"journal":{"name":"European Heart Journal","volume":"9 1","pages":""},"PeriodicalIF":39.3,"publicationDate":"2025-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144603765","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信